In the mouse model of CKD via unilateral ureteral obstruction, FXR activation attenuates kidney fibrosis by suppressing SMAD3 expression but does not alter the mRNA levels of SMAD2 and SMAD460. The gene discussed is NR1H4; the disease is chronic kidney disease.